Quality of life is associated with physical activity and fitness in cystic fibrosis

Helge Hebestreit, Kerstin Schmid, Stephanie Kieser, Sibylle Junge, Manfred Ballmann, Kristina Roth, Alexandra Hebestreit, Thomas Schenk, Christian Schindler, Hans-Georg Posselt, Susi Kriemler, Helge Hebestreit, Kerstin Schmid, Stephanie Kieser, Sibylle Junge, Manfred Ballmann, Kristina Roth, Alexandra Hebestreit, Thomas Schenk, Christian Schindler, Hans-Georg Posselt, Susi Kriemler

Abstract

Background: Health-related and disease-specific quality of life (HRQoL) has been increasingly valued as relevant clinical parameter in cystic fibrosis (CF) clinical care and clinical trials. HRQoL measures should assess - among other domains - daily functioning from a patient's perspective. However, validation studies for the most frequently used HRQoL questionnaire in CF, the Cystic Fibrosis Questionnaire (CFQ), have not included measures of physical activity or fitness. The objective of this study was, therefore, to determine the cross-sectional and longitudinal relationships between HRQoL, physical activity and fitness in patients with CF.

Methods: Baseline (n = 76) and 6-month follow-up data (n = 70) from patients with CF (age ≥12 years, FEV1 ≥35%) were analysed. Patients participated in two multi-centre exercise intervention studies with identical assessment methodology. Outcome variables included HRQoL (German revised multi-dimensional disease-specific CFQ (CFQ-R)), body composition, pulmonary function, physical activity, short-term muscle power, and aerobic fitness by peak oxygen uptake and aerobic power.

Results: Peak oxygen uptake was positively related to 7 of 13 HRQoL scales cross-sectionally (r = 0.30-0.46). Muscle power (r = 0.25-0.32) and peak aerobic power (r = 0.24-0.35) were positively related to 4 scales each, and reported physical activity to 1 scale (r = 0.29). Changes in HRQoL-scores were directly and significantly related to changes in reported activity (r = 0.35-0.39), peak aerobic power (r = 0.31-0.34), and peak oxygen uptake (r = 0.26-0.37) in 3 scales each. Established associates of HRQoL such as FEV1 or body mass index correlated positively with fewer scales (all 0.24 < r < 0.55).

Conclusions: HRQoL was associated with physical fitness, especially aerobic fitness, and to a lesser extent with reported physical activity. These findings underline the importance of physical fitness for HRQoL in CF and provide an additional rationale for exercise testing in this population.

Trial registration: ClinicalTrials.gov, NCT00231686.

References

    1. Goss CH, Quittner AL. Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc. 2007;4:378–386. doi: 10.1513/pats.200703-039BR.
    1. Abbott J, Hart A. Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review. Health Qual Life Outcomes. 2005;3:19. doi: 10.1186/1477-7525-3-19.
    1. Abbott J, Hart A, Morton AM, Dey P, Cornway SP, Webb AK. Can health-related quality of life predict survival in adults with cystic fibrosis? Am J Respir Crit Care Med. 2009;179:54–58. doi: 10.1164/rccm.200802-220OC.
    1. Gee L, Abbott J, Conway SP, Etherington C, Webb AK. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax. 2000;55:946–954. doi: 10.1136/thorax.55.11.946.
    1. Quittner AL, Buu A, Messer MA, Modi AC, Watrous M. Development and validation of the cystic fibrosis questionnaire in the United States - a health-related quality-of-life measure for cystic fibrosis. Chest. 2005;128:2347–2354. doi: 10.1378/chest.128.4.2347.
    1. Bize R, Johnson JA, Plotnikoff RC. Physical activity level and health-related quality of life in the general adult population: a systematic review. Prev Med. 2007;45:401–415. doi: 10.1016/j.ypmed.2007.07.017.
    1. Sloan RA, Sawada SS, Martin CK, Church T, Blair SN. Associations between cardiorespiratory fitness and health-related quality of life. Health Qual Life Outcomes. 2009;7:47. doi: 10.1186/1477-7525-7-47.
    1. Selvadurai HC, Blimkie CJ, Cooper PJ, Mellis CM, Van Asperen PP. Gender differences in habitual activity in children with cystic fibrosis. Arch Dis Child. 2004;89:928–933. doi: 10.1136/adc.2003.034249.
    1. Orenstein DM, Nixon PA, Ross EA, Kaplan RM. The quality of well-being in cystic fibrosis. Chest. 1989;95:344–347. doi: 10.1378/chest.95.2.344.
    1. Congleton J, Hodson ME, Duncan-Skingle F. Do Nottingham Health Profile scores change over time in cystic fibrosis? Respir Med. 1998;92:268–272. doi: 10.1016/S0954-6111(98)90107-X.
    1. Wenninger K, Aussage P, Wahn U, Staab D. and the Germany CFQ study group. The revised German Cystic Fibrosis Questionnaire: validation of a disease-specific health-related quality of life instrument. Qual Life Res. 2003;12:77–85. doi: 10.1023/A:1022011704399.
    1. Groeneveld IF, Sosa ES, Pérez M, Fiuza-Luces C, Gonzalez-Saiz L, Gallardo C, López-Mojares LM, Ruiz JR, Lucia A. Health-related quality of life of Spanish children with cystic fibrosis. Qual Life Res. 2012;21:1837–1845. doi: 10.1007/s11136-011-0100-8.
    1. Hebestreit H, Kieser S, Junge S, Ballmann M, Hebestreit A, Schenk T, Posselt HG, Kriemler S. Long-term effects of a partially supervised conditioning programme in cystic fibrosis. Eur Respir J. 2010;35:578–583. doi: 10.1183/09031936.00062409.
    1. Kriemler S, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C, Stüssi C, Hebestreit H. Effect of supervised training on FEV1 in cystic fibrosis. J Cyst Fibros. 2013;12:714–720. doi: 10.1016/j.jcf.2013.03.003.
    1. Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD, Bemben DA. Skinfold equations for estimation of body fatness in children and youth. Hum Biol. 1988;60:709–723.
    1. Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;32:77–97. doi: 10.1079/BJN19740060.
    1. Sherrill DL, Lebowitz MD, Knudson RJ, Burrows B. Continuous longitudinal regression equations for pulmonary function measures. Eur Respir J. 1992;5:452–462.
    1. Inbar O, Bar-Or O, Skinner JS. The Wingate Anaerobic Test. Champaign, IL: Human Kinetics; 1996.
    1. Williams CA, Doré E, Alban J, van Praagh E. Short-term power output in 9-year-old children: typical error between ergometers and protocols. Ped Exerc Sci. 2003;15:302–312.
    1. Godfrey S, Davies CTM, Wozniak E, Barnes CA. Cardio-respiratory response to exercise in normal children. Clin Sci. 1971;40:419–431.
    1. Orenstein DM. In: Pediatric Laboratory Exercise Testing. Clinical Guideline.s. Rowland TW, editor. Champaign, IL: Human Kinetics; 1993. Assessment of exercise pulmonary function; pp. 141–163.
    1. Sallis JF, Haskell WL, Wood PD, Fortmann SP, Rogers T, Blair SN, Paffenbarger RS Jr. Physical activity assessment methodology in the five-city project. Am J Epidemiol. 1985;121:91–106.
    1. Sallis JF, Buono MJ, Roby JJ, Micale FG, Nelson JA. Seven-day recall and other physical activity self-reports in children and adolescents. Med Sci Sports Exerc. 1993;25:99–108. doi: 10.1249/00005768-199301000-00014.
    1. Ruf KC, Fehn S, Bachmann M, Moeller A, Roth K, Kriemler S, Hebestreit H. Validation of activity questionnaires in patients with cystic fibrosis by accelerometry and cycle ergometry. BMC Med Res Methodol. 2012;12:43. doi: 10.1186/1471-2288-12-43.
    1. Hebestreit H, Kieser S, Rüdiger S, Schenk T, Junge S, Hebestreit A, Ballmann M, Posselt HG, Kriemler S. Physical activity is independently related to aerobic capacity in cystic fibrosis. Eur Resp J. 2006;28:734–739. doi: 10.1183/09031936.06.00128605.
    1. McGlone S, Venn A, Walters EH. Physical activity, spirometry and quality-of-life in chronic obstructive pulmonary disease. COPD. 2006;3:83–88. doi: 10.1080/15412550600651263.
    1. Chan CB, Ryan DA, Tudor-Locke C. Relationship between objective measures of physical activity and weather: a longitudinal study. Int J Behav Nutr Phys Act. 2006;3:21. doi: 10.1186/1479-5868-3-21.
    1. Corder K, Ekelund U, Steele RM, Wareham NJ, Brage S. Assessment of physical activity in youth. J Appl Physiol. 2008;105:977–987. doi: 10.1152/japplphysiol.00094.2008.
    1. Selvadurai HC, Blimkie CJ, Meyers N, Mellis CM, Cooper PJ, VanAsperen PP. Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis. Pediatr Pulmonol. 2002;33:194–200. doi: 10.1002/ppul.10015.
    1. Orenstein DM, Franklin BA, Doerchuk CF, Hellerstein HK, Germann KJ, Horowitz JG, Stern RC. Exercise conditioning and cardiopulmonary fitness in cystic fibrosis. The effects of a three-month supervised running program. Chest. 1981;80:392–398.
    1. Raglin JS, Morgan WP. O´Connor PJ: Changes in mood states during training in female and male college swimmers. Int J Sports Med. 1991;12:585–589. doi: 10.1055/s-2007-1024739.
    1. Orenstein DM, Hovell MF, Mulvihill M, Keating KK, Hofstetter R, Kelsey S, Morris K, Nixon PA. Strength vs aerobic training in children with cystic fibrosis. Chest. 2004;126:1204–1214. doi: 10.1378/chest.126.4.1204.
    1. Adams SA, Matthews CE, Ebbeling CB, Moore CG, Cunningham JE, Fulton J, Hebert JR. The effect of social desirability and social approval on self-reports of physical activity. Am J Epidemiol. 2005;161:389–398. doi: 10.1093/aje/kwi054.
    1. Schneiderman-Walker J, Pollock SL, Corey M, Wilkes DD, Canny GJ, Pedder L, Reisman JJ. A randomized controlled trial of a three year home exercise program in cystic fibrosis. J Pediatr. 2000;136:304–310. doi: 10.1067/mpd.2000.103408.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi